<

 
Data updated 2025-05-13 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date06752445.4 (espacenet)  (Federated)  (European Patent Register), 20060510
Patent/reg. no. and dateDK/EP 1885187, 20130925
Publication date20080213
Priority no. and dateUS 680722 P, 20050513
EP pub. no. and date EP 1885187 20080213
Effective date
Applicant/ownerNovartis AG, Lichtstrasse 35
4056 Basel, CH
Applicant ref. no.NGC/AP/147750
InventorMICHELSON, Glenn C., c/o Novartis AG
Post Office Box 8097
Emeryville,
California 94662-8097, US,
CHAN, Vivien W., c/o Novartis AG
Post Office Box 8097
Emeryville,
California 94662-8097, US,
HEISE, Carla C., c/o Novartis AG
Post Office Box 8097
Emeryville,
California 94662-8097, US,
WIESMANN, Marion, c/o Novartis AG
Post Office Box 8097
Emeryville,
California 94662-8097, US,
DAWES, Timothy D., c/o Novartis AG
Post Office Box 8097
Emeryville,
California 94662-8097, US
RepresentativeBudde Schou A/S, Dronningens Tværgade 30, 1302 København K
Opponent
IPC ClassA61K 31/4184 (2006.01) , A61K 31/4425 (2006.01) , A61K 31/497 (2006.01) , A61K 35/00 (2006.01) 
TitleFremgangsmåde til behandling af lægemiddelresistent cancer
Int. application no.US2006017922
Int. publication no.WO2006124413
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact